Skip to main content

Salinocaine

NDC 10733-415 · Medical Products Laboratories, Inc.

Generic namesalicylic acid and benzocaine
Dosage formOINTMENT
RouteTOPICAL
Active ingredient(s)SALICYLIC ACID, BENZOCAINE
Strength20; 550 mg/g; mg/g
Pharmacologic classAllergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]
Marketing categoryUNAPPROVED DRUG OTHER

Packages

10733-415-40 — 40 g in 1 JAR (10733-415-40)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

10733-162 — Benzocaine, 10733-166 — Benzocaine, 10733-167 — Benzocaine, 10733-169 — Benzocaine, 10733-170 — Benzocaine, 10733-171 — Benzocaine, 10733-173 — Benzocaine, 10733-174 — Benzocaine, 10733-175 — Benzocaine, 10733-176 — Benzocaine, 10738-045 — Shampoo, 10738-062 — Salicylic Acid, 10738-217 — SALICYLIC ACID, 10738-980 — SALICYLIC ACID, 10742-1000 — salicylic acid, 10742-1005 — Salicylic acid 0.5%, 10742-1006 — Salicylic acid 2%, 10742-1007 — Salicylic acid 0.5%, 10742-1008 — Salicylic acid 2%, 10742-1009 — Oxy Hydrating Anti-Blemish Body Wash, +2028 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels